Common Contracts

First Amendment to lbs-008 research and development services agreement

Services Agreement • April 5th, 2022 • Belite Bio, Inc • Pharmaceutical preparations

• Contract Type
  Services Agreement
• Filed
  April 5th, 2022
• Company
  Belite Bio, Inc
• Industry
  Pharmaceutical preparations

This First Amendment to LBS-008 Research and Development Services Agreement (this “Amendment”), effective as of Feb 23, 2022 (“Effective Date”), is entered into by and between Belite Bio, Inc, a Cayman corporation, with contact office located at 5820 Oberlin Drive, Suite 101, San Diego CA, 92121 USA (“Belite Inc”) and Lin BioScience, Inc., a Taiwan corporation, located at 12F., No.68, Sec. 5, Zhongxiao E. Rd., Xinyi Dist., Taipei City 110, Taiwan (“Lin Inc.”).

First Amendment to lbs-008 research and development services agreement

Services Agreement • March 15th, 2022 • Belite Bio, Inc • Pharmaceutical preparations

• Contract Type
  Services Agreement
• Filed
  March 15th, 2022
• Company
  Belite Bio, Inc
• Industry
  Pharmaceutical preparations

This First Amendment to LBS-008 Research and Development Services Agreement (this “Amendment”), effective as of Feb 23, 2022 (“Effective Date”), is entered into by and between Belite Bio, Inc, a Cayman corporation, with contact office located at 5820 Oberlin Drive, Suite 101, San Diego CA, 92121 USA (“Belite Inc”) and Lin BioScience, Inc., a Taiwan corporation, located at 12F., No.68, Sec. 5, Zhongxiao E. Rd., Xinyi Dist., Taipei City 110, Taiwan (“Lin Inc.”).